Vistin Pharma ASA
Oslo, Norway, 12 February 2020
Vistin Pharma ASA will release its fourth quarter 2020 results on Friday 19th of February 2021. Vistin Pharma will host a conference call for all shareholders and interested parties on Friday 19th of February at 08:30 CET. There will be a Q&A session following the management discussion.
The conference call will be held in Norwegian.
The fourth quarter conference call will be available via web and audio through the following access points:
Telephone conference:
Confirmation Code:........ 3067548
International Dial-In:........ +44 (0) 2071 928338
Norway, Oslo:................ +47 21563015
United States, New York: +1 6467413167
Webcast:
https://edge.media-server.com/mmc/p/c6wg4zco
****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Global Electronics Association16.12.2025 18:46:06 CET | Press release
Historic First for Sustainability Reporting in Europe and Beyond
Sodexo SA16.12.2025 18:40:00 CET | Press release
Sodexo: Combined Shareholders Meeting of December 16, 2025
Alvotech16.12.2025 17:48:19 CET | Press release
Alvotech Launches $100 Million Senior Unsecured Convertible Bond Offering to Continue Strong Investment in R&D, Support Manufacturing, Global Product Launches and Enhance Liquidity Position, reaffirms 2025 outlook and provides 2026 guidance
Ageas16.12.2025 17:40:00 CET | Press release
Karolien Gielen succeeds Filip Coremans as Managing Director Asia and takes up the role of Managing Director Asia and Business Development
Aspo Plc16.12.2025 17:30:00 CET | Press release
Aspo Plc: Share repurchase 16.12.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
